Category

Cohort News

Anumana wins FDA clearance for ECG-AI algorithm

//
Categories
Anumana announced that it received FDA 510(k) clearance for its AI-powered ECG-AI LEF medical device. Cambridge, Massachusetts–based Anumana, an Nference portfolio company, worked in collaboration with Mayo Clinic. They designed the breakthrough medical device to detect low ejection fraction (LEF) in patients...
Read More →

Addressing the Cost vs. Quality Conundrum: 3EO Health Receives FDA Emergency Use Authorization, Launches Groundbreaking Point of Care Technology

//
Categories
3EO’s novel technology enables up to 70% savings versus existing point of care molecular tests. Demonstrated strong clinical performance of 95% PPA and 100% NPA. Delivers enhanced ease-of-use via a preparation-free workflow. BOSTON–(BUSINESS WIRE)–3EO Health, a “Point of Life” diagnostics...
Read More →